Holen Sie sich die Stockscreener-App
303.79
2.10%
-5.9144
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
Deutsche Bank Adjusts West Pharmaceutical Services PT to $340 From $315, Maintains Buy Rating - marketscreener.com
Jefferies Adjusts West Pharmaceutical Services Price Target to $365 From $295, Maintains Buy Rating - marketscreener.com
TD Cowen Adjusts West Pharmaceutical Services PT to $365 From $350, Maintains Buy Rating - marketscreener.com
West Pharmaceutical: A High-Quality Beat-And-Raise With More Upside Ahead - Seeking Alpha
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2026 Earnings Call Transcript - Insider Monkey
West Pharmaceutical Services Q1 Earnings Call Highlights - Yahoo Finance
West Pharmaceutical Services Inc (WST) Q1 2026 Earnings Call Hig - GuruFocus
WST Q1 Deep Dive: High-Value Components and Operational Execution Drive Outperformance - TradingView
West Pharmaceutical: Q1 Earnings Snapshot - theheraldreview.com
West Pharma lifts 2026 profit forecast on strong demand for medical equipment - 1470 & 100.3 WMBD
West Pharmaceutical Lifts Outlook After Powerful Q1 - TipRanks
BofA raises West Pharmaceutical stock price target on strong quarter By Investing.com - Investing.com Canada
A Look at West Pharmaceutical Services Inc (WST) After 12.9% Gai - GuruFocus
TD Cowen raises West Pharmaceutical stock price target on guidance By Investing.com - Investing.com Australia
West Pharma sees plastics, elastomer demand surge with GLP-1 growth - Rubber News
[10-Q] WEST PHARMACEUTICAL SERVICES INC Quarterly Earnings Report - Stock Titan
WST Stock Climbs As Dublin Expansion Targets GLP‑1 Drug Wave - StocksToTrade
WST Stock Climbs As Dublin Expansion Targets GLP-1 Drug Boom - timothysykes.com
West Pharmaceutical Lifts Annual Guidance After Strong GLP-1 Driven Growth In Q1 - Benzinga
West Pharmaceutical Services, Inc. Raises Earnings Guidance for the Full Year 2026 - marketscreener.com
West Pharma jumps as packaging components drive strong Q1 beat - MSN
West Pharmaceutical Services Q1 2026 Earnings Call Transcript - MarketBeat
Evercore ISI raises West Pharmaceutical price target on strong results By Investing.com - Investing.com Canada
West Pharmaceutical Services, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
West Pharmaceutical Stock Is Soaring After Earnings. It’s a Sneaky GLP-1 Play. - Barron's
WST Stock Jumps on Q1 Earnings & Sales Beat, EPS View Up on HVP Growth - TradingView
WST Stock Climbs As Dublin Expansion Targets GLP‑1 Drug Boom - StocksToTrade
West Pharmaceutical Services Reports Strong Q1 2026 Results Driven by Double-Digit Organic Net Sales Growth - Minichart
West Pharmaceutical (WST) jumps on Q1 beat and raised 2026 outlook - Quiver Quantitative
West Pharmaceutical Services Stock Climbs As Dublin Expansion Targets Obesity Drug Boom - timothysykes.com
West Pharmaceutical Q1 2026 slides: 47% EPS surge on biologics boom - Investing.com
West Pharmaceutical Services Crushes Q1 2026 Profit Estimates by 26.0% - AlphaStreet
West Pharmaceutical Q1 2026 slides: 47% EPS surge on biologics boom By Investing.com - Investing.com South Africa
West Pharma Sees FY EPS $8.15-EPS $8.50 >WST - Moomoo
West Pharmaceutical Services CEO Eric Green plans to retire after successor is named - MSN
Compared to Estimates, West Pharmaceutical (WST) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Earnings call transcript: West Pharmaceutical Services Q1 2026 beats expectations - Investing.com Canada
West Pharmaceutical Services, Inc. Provides Earnings Guidance for the Second Quarter 2026 - marketscreener.com
West Pharma stock jumps after strong Q1 beat (WST:NYSE) - Seeking Alpha
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Is West Pharmaceutical (WST) 23.2% Undervalued After Q1 2026 Bea - GuruFocus
West Pharmaceutical Raises 2026 Outlook After Strong Quarter - TipRanks
West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Form 8-K WEST PHARMACEUTICAL SERV For: Apr 23 - StreetInsider
West (NYSE: WST) posts 21% Q1 sales growth and raises 2026 guidance - Stock Titan
Why West Pharmaceutical Services Stock Is Dropping Now - TipRanks
WEST PHARMACEUTICAL SVSC ($WST) Releases Q1 2026 Earnings - Quiver Quantitative
(WST) West Pharmaceutical Services Expects Full Year 2026 Adjusted EPS Range $8.40$8.75, vs. FactSet Est of $8.01 - marketscreener.com
(WST) West Pharmaceutical Expects 2026 Revenue Range $3.3B$3.35B, vs. FactSet Est of $3.25B - marketscreener.com
(WST) West Pharmaceutical Services, Inc. Expects Q2 Revenue Range $830.0M$850.0M - marketscreener.com
(WST) West Pharmaceutical Services, Inc. Expects Q2 Adjusted EPS Range $2.05$2.12 - marketscreener.com
Earnings Flash (WST) West Pharmaceutical Services, Inc. Reports Q1 Revenue $844.9M, vs. FactSet Est of $780.3M - marketscreener.com
Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q1 Adjusted EPS $2.13 per Share, vs. FactSet Est of $1.68 - marketscreener.com
West Pharmaceutical Services (NYSE:WST) Surprises With Strong Q1 CY2026, Stock Soars - Yahoo Finance
West Reports First-Quarter 2026 Results - The Malone Telegram
West Pharmaceutical Q1 2026 earnings preview - MSN
West Pharmaceutical earnings loom as GLP-1 exposure in focus By Investing.com - Investing.com Australia
West Pharmaceutical earnings loom as GLP-1 exposure in focus - Investing.com
Earnings To Watch: West Pharmaceutical Services (WST) Reports Q1 Results Tomorrow - Yahoo Finance
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
WST Likely to Beat Q1 Earnings Estimates: How to Play the Stock? - TradingView
Exploring Analyst Estimates for West Pharmaceutical (WST) Q1 Earnings, Beyond Revenue and EPS - Yahoo Finance
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services (WST): Strong Buy Ratings And A Promising 15.98% Upside - DirectorsTalk Interviews
Reasons to retain West Pharmaceutical stock in your portfolio for now - MSN
West Pharmaceutical Services, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Assessing West Pharmaceutical Services (WST) Valuation After Recent Share Price Momentum - Sahm
1.24%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):